Insider Trading & Ownership - Saik Andrew

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Saik Andrew
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-09-08
Purchase
2020-09-08
8:01 pm
VYNE Therapeutics Inc.VYNESaik Andrew
Chief Financial Officer
40,000$1.462$58,480340,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-28
Option Award
2024-08-29
4:15 pm
N/A
2034-08-28
Milestone Pharmaceuticals Inc.MISTSaik Andrew
Director
40,000$040,000
(Direct)
View
2024-07-15
Option Award
2024-07-17
4:17 pm
N/A
2034-07-15
Milestone Pharmaceuticals Inc.MISTSaik Andrew
Director
80,000$080,000
(Direct)
View
2024-06-24
Option Award
2024-06-26
4:20 pm
N/A
2034-06-23
ARVINAS INC.ARVNSaik Andrew
Chief Financial Officer
155,827$0155,827
(Direct)
View
2023-11-08
Equity Swap
2023-11-13
2:40 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
23,021$190
(Direct)
View
2023-11-08
Disposition
2023-11-13
2:40 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
45,244$190
(Direct)
View
2023-11-08
Disposition
2023-11-13
2:40 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
114,140$00
(Direct)
View
2023-09-21
Tax Withholding
2023-09-25
4:01 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
908$10.868,265
(Direct)
View
2023-06-21
Tax Withholding
2023-06-23
4:04 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
908$11.7469,173
(Direct)
View
2023-03-21
Tax Withholding
2023-03-23
4:01 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
909$14.1970,081
(Direct)
View
2023-01-27
Option Award
2023-01-31
4:05 pm
N/A
2033-01-27
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
38,700$094,990
(Direct)
View
2022-12-31
Tax Withholding
2023-01-03
4:04 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
718$12.3756,290
(Direct)
View
2022-12-21
Tax Withholding
2022-12-23
4:03 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
908$13.4357,008
(Direct)
View
2022-09-21
Tax Withholding
2022-09-23
4:02 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
908$14.8557,916
(Direct)
View
2022-06-21
Tax Withholding
2022-06-23
4:01 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
3,632$12.4858,824
(Direct)
View
2022-01-27
Option Award
2022-01-31
4:16 pm
N/A
2032-01-27
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
27,900$080,056
(Direct)
View
2021-06-21
Option Award
2021-06-22
7:01 pm
N/A
2031-06-21
INTERCEPT PHARMACEUTICALS INC.ICPTSaik Andrew
EVP & Chief Financial Officer
124,696$0124,696
(Direct)
View
2021-05-28
Option Award
2021-06-02
4:31 pm
N/A
N/A
VYNE Therapeutics Inc.VYNESaik Andrew
Chief Financial Officer
3,017$3.3575116,468
(Direct)
View
2021-03-31
Tax Withholding
2021-04-02
12:14 pm
N/A
N/A
VYNE Therapeutics Inc.VYNESaik Andrew
Chief Financial Officer
762$6.84113,451
(Direct)
View
2021-02-22
Option Award
2021-02-24
4:39 pm
N/A
2031-02-22
VYNE Therapeutics Inc.VYNESaik Andrew
Chief Financial Officer
97,375$0182,375
(Direct)
View
2020-05-06
Option Award
2020-05-08
5:54 pm
N/A
2030-05-06
Menlo Therapeutics Inc.MNLOSaik Andrew
Chief Financial Officer
250,000$0550,000
(Direct)
View
2020-03-23
Option Award
2020-03-24
4:31 pm
N/A
2030-03-23
Menlo Therapeutics Inc.MNLOSaik Andrew
Chief Financial Officer
150,000$0150,000
(Direct)
View
2020-02-14
Option Award
2020-02-19
4:30 pm
N/A
N/A
PDS Biotechnology CorpPDSBSaik Andrew
Chief Financial Officer
38,400$1.342,549
(Direct)
View